Drug Screening Market Share is booming in next 10 years | Danaher Corporation, Quest Diagnostics Incorporated and, Express Diagnostics International Inc.

Drug screening test analyses biological samples, such as blood, hair, & urine; to diagnose the presence of drug abuse or its metabolites in patient's body. Drug screening tests are used to determine if person is or was under the influences of drug at a certain point of time. Drug screening devices have improved owing to introduction of new technology; offering the users precise and accurate results. Rise in alcohol consumption among youth as well as elderly population, overuse of prescribed drugs, increase in use of narcotics and illicit drugs is a major driver for the market.

Request Sample of the Report on: https://www.alliedmarketresearch.com/request-sample/1070

Market Segmentation

The global drug screening market is segmented based on equipment and services, sample type, end user, and geography. Based on equipment and services, the drug screening market is divided into immunoassay analyzers, chromatography instruments, breath analyzers, breath analyzers, rapid testing devices, and urine testing devices. The breath analyzers are further classified into fuel cell breath analyzers, semiconductor breath analyzers, and other devices. The RTD (rapid testing devices) is bifurcated into urine testing devices and oral fluid/saliva testing devices. The urine testing devices are further classified into urine testing cups, dip cards and cassettes Based on consumables assay kits, sample collection cups, calibrators & controls, and other consumables. Laboratory services hold major market share in this segment. The sample type segment is divided into urine sample, breath sample, oral fluid sample, hair sample, and other sample (blood & sweat). Urines sample are widely used and draw a large amount of share in this segment. Based on end user, the industry is divided into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, drug treatment centers, pain management centers, and personal users.

The impact of the driving factors is expected to overcome the effect of restraints. Increase in consumption of alcohol and illicit drugs, establishment of stringent laws in various countries, and increase in governmental funding to control drug trafficking provide opportunity for the drug screening devices. Immunoassay analyzers occupied the largest share in the drug screening equipment market in 2024.

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/1070

Competitive Landscape

Key players operating in this drug screening market include Alere, Inc., Drägerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and, Express Diagnostics International Inc.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/1070

Key Benefits:

The study provides an in-depth analysis of the global drug screening market size with current trends and future estimations from 2024 to 2033 to elucidate the imminent investment pockets.

Comprehensive analysis of factors that drive and restrict the drug screening market growth is provided.

Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.

Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the drug screening market.

Contact

David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int'l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.